ELMSFORD, N.Y.--(BUSINESS WIRE)--March 2, 2006--BioScrip, Inc. (NASDAQ: BIOS) today announced that it has acquired Intravenous Therapy Services ("ITS"), a specialty infusion company located in Burbank, California. In addition, the Company announced that it has increased its existing revolving
ELMSFORD, N.Y. & MINNEAPOLIS, Oct 11, 2005 (BUSINESS WIRE) -- BioScrip, Inc. (NASDAQ:BIOS) today announced that it has acquired Northland Medical Pharmacy ("Northland"), a community-based specialty pharmacy, located in Columbus, Ohio. Henry F. Blissenbach, BioScrip's President and Chief Executive
Amendment Further Enhances Value for Shareholders Accretive Transaction Provides Substantial Operating Synergies and Deleveraging Opportunity DENVER and HAMMONTON, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of
DENVER and HAMMONTON, N.J. , Sept. 02, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions and HS Infusion Holdings, Inc. ("Home Solutions"), today announced that they have further amended
Financial Impact Estimated at $2.0 Million for 2009 ELMSFORD, N.Y., Sep 11, 2008 (BUSINESS WIRE) -- BioScrip, Inc. (Nasdaq: BIOS) announced today that UnitedHealthcare, a UnitedHealth Group (NYSE: UHG) company, has notified the Company of its intention to internalize services for HIV/AIDS and Solid
ELMSFORD, N.Y. , Sept. 11, 2013 /PRNewswire/ -- BioScrip®, Inc. (NASDAQ: BIOS) today announced its inaugural Investor Day to be held Tuesday, September 24, 2013 , at Le Parker Meridien located at 119 West 56th Street in New York City . (Logo: http://photos.prnewswire.com/prnh/20130117/NY44138LOGO
Appoints Harriet Booker as Senior Vice President, Chief Operating Officer and Danny R. Claycomb as Senior Vice President, Revenue Cycle Management DENVER , Nov. 28, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of
DENVER , Jan. 06, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it has entered into an agreement to amend its existing Credit Agreement (the “Amendment”), dated
Reaffirms Guidance ELMSFORD, N.Y. --(BUSINESS WIRE)-- BioScrip, Inc. (Nasdaq: BIOS), announced today that it will record a fourth quarter non-cash, after-tax charge of approximately $80.0 million for the impairment of goodwill and the write off of intangible assets in accordance with Statement of
DENVER , Oct. 05, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, is pleased to announce that it can now dispense and administer Radicava® (edaravone), the first treatment